We’re excited to announce the launch of Garuda Therapeutics with $72 million in Series A financing. Co-founded by @ShahDhvanit, Kiran Reddy, David Scadden, and @SJMorrison_, Garuda is committed to changing the world of blood stem cell transplants. More @ https://t.co/3uRAptMLM1
For junior faculty members, reviewing manuscripts for journals you want to publish in can be an excellent opportunity to create positive relationships with editors & help publish future papers. As part of the #CRIHack series @SJMorrison_ shares the best way to review manuscripts.
Delighted to share our paper published today: “Interrogation of Enhancer Function by Enhancer-Targeting CRISPR Epigenetic Editing”
https://t.co/UZtkcIaFOb
Congrats to Kailong, Yuxuan and other co-authors for a great teamwork! @CRI_UTSW@UTSWNews@NatureComms
Twittorial below:
@AlfredChung11 Alfred: Please remove a slide of our unpublished data. Yoda picture looks awesome. Thanks so much for your consideration of my request and your enthusiasm!
3 years ago Hanna spent 7 months in chemo and radiation therapy. She beat the cancer and is back publishing @Nature. Her toughness, determination, and perseverance is one of the most inspiring things I’ve ever seen. Next time you think you’re having a rough day, think of Hanna.